Doctor suggests 8 essential health checkups to detect hidden lifestyle disorders early, helping you manage your health better.

Doctor suggests 8 essential health checkups to detect hidden lifestyle disorders early, helping you manage your health better ...
Medical Dialogues

Simple test can predict risk of severe liver disease, finds study

A new study from Karolinska Institutet, published in the scientific journal The BMJ, shows how a simple blood analysis can ...

This Simple Test Can Predict Risk of Severe Liver Disease Up to 10 Years in Advance

A Swedish team created a test that predicts severe liver disease years ahead. It could help doctors detect risk early using routine blood data. A recent study from Karolinska Institutet, published in ...
The Malaysian Reserve

Lilly’s Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...
Lupus Science & Medicine

Clinical characteristics and prognostic factors in adult macrophage activation syndrome: an observational study in a Chinese cohort

Objective Macrophage activation syndrome (MAS), a subtype of secondary haemophagocytic lymphohistiocytosis (HLH), is a rare ...

Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Ann…

Eli Lilly and Company (NYSE: LLY) today announced that new data from across its oncology portfolio and pipeline will be ...

IMFINZI® (durvalumab)-based regimen reduced the risk of death by 22% in early gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types

Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types ...